Related Experiment Video

Updated: Aug 12, 2026

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung
07:46

Use of Artificial Sputum Medium to Test Antibiotic Efficacy Against Pseudomonas aeruginosa in Conditions More Relevant to the Cystic Fibrosis Lung

Published on: June 5, 2012

Spiramycin vs. placebo for treatment of acute diarrhea caused by Cryptosporidium

X Sáez-Llorens1, C M Odio, M A Umaña

  • 1Hospital Nacional de Niños, San José, Costa Rica.

The Pediatric Infectious Disease Journal
|March 1, 1989
PubMed

Insights

Spiramycin treatment shortened diarrhea duration and oocyst shedding in infants with Cryptosporidium infections. This antibiotic showed promise for managing pediatric cryptosporidiosis.

Area of Science:

  • Infectious Diseases
  • Pediatrics
  • Parasitology

Background:

  • Cryptosporidium is a significant cause of acute diarrhea in infants.
  • Effective treatments for cryptosporidiosis in immunocompetent children are limited.

Purpose of the Study:

  • To evaluate the efficacy of spiramycin in treating acute diarrhea caused by Cryptosporidium in infants.
  • To assess the impact of spiramycin on the duration of diarrhea and oocyst excretion.

Main Methods:

  • A double-blind, placebo-controlled study involving 44 immunocompetent infants (2-13 months old).
  • Participants received either spiramycin (100 mg/kg/day) or a placebo for 10 days.
  • Clinical outcomes and oocyst shedding were monitored.

Main Results:

  • Spiramycin group showed a shorter mean duration of diarrhea (5.2 vs. 7.3 days; P=0.002).
  • Duration of oocyst excretion was also reduced in the spiramycin group (7.1 vs. 8.5 days; P=0.032).
  • Mild adverse effects were observed in 10% of patients receiving spiramycin.

Conclusions:

  • Spiramycin effectively reduced diarrhea duration and oocyst shedding in infants with cryptosporidiosis.
  • The drug appears to accelerate clinical recovery and decrease parasite shedding.
  • Spiramycin is a potentially beneficial treatment option for pediatric cryptosporidiosis.

More Related Videos

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians06:49

Reduced Itraconazole Concentration and Durations Are Successful in Treating Batrachochytrium dendrobatidis Infection in Amphibians

Published on: March 14, 2014

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment12:58

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment

Published on: May 25, 2017

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation. 
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...